Searched for
ZYDUS CADILA PHARMACEUTICALS
These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Cadila inks pact with Italian firm to launch generic product in USThe partners plan to launch the product which is a generic version of Sanofi Aventis's Lovenox (Enoxaparin Sodium Injection) in seven dosag...
- Zydus Pharmaceuticals Inc among cos facing lawsuit by US states: CadilaIn a regulatory filing, Cadila said in its opinion this particular matter is not likely to have any material impact on the operations and f...
- Zydus gets USFDA nod for schizophrenia treatment drugThe company has got final approval from the USFDA to market the drug in the strengths of 25 mg, 50 mg, 100 mg and 200 mg, Zydus Cadila said...
- Zydus' Nesher Pharma gets USFDA nod to market influenza drugZydus' Nesher Pharmaceuticals has received final approval from the USFDA to market Oseltamivir powder for oral suspension, 6 mg/ml, said th...
- Cadila inks pact with Supernus Pharma to settle patent issueCadila Healthcare have finalised an agreement with Supernus Pharmaceuticals Inc to settle all outstanding patent litigation.
- Zydus gets USFDA nod for morphine sulfate tabletsZydus Group today announced receipt of approval to sell chronic pain reliever morphine sulfate tablets from the US Food and Drug Administra...
- Cadila Healthcare recalls 19,536 bottles of cough treatment drug in USDrug firm Cadila is voluntarily recalling 19,536 bottles of benzonatate capsules, used to treat coughs, in the US due to "wet and/or leakin...
- Cadila Healthcare recalls 15,144 bottles of hypertension drug in USAs per information available on the USFDA website, Zydus Pharmaceuticals USA Inc, the US-based arm of the company, is recalling the drug du...
- Zydus Cadila gets USFDA approval for anti-viral drug AcyclovirPharmaceutical major Zydus Cadila has received final approval from United States Food & Drug Administration for marketing of Acyclovir.
- Cadila Healthcare, Zydus Pharmaceuticals to settle patent infringement case with Depomed IncThe settlement will allow Cadila and Zydus to begin sell of generic versions of Gralise on January 1, 2024, or earlier under certain circum...
- Warner Chilcott & Cadila Healthcare settles patent litigationIndia's fifth largest drug maker by revenue, Zydus Cadila Group has settled a patent litigation with US-based Warner Chilcott Company LLC.
- Zydus Cadila Group to merge its three subsidiaries with its listed entity Cadila Healthcare LtdIn 2000, Zydus Cadila had created a strategic alliance with Ambalal Sarabhai Enterprises to integrate the animal healthcare business of bot...
- Cadila Healthcare to merge certain subsidiaries with itselfDrug maker Cadila Healthcare today said its board has approved the merger of various wholly-owned subsidiaries, including Zydus Animal Heal...
- Zydus Cadila buys out Biochem PharmaceuticalsZydus Cadila has acquired 100% stake in Mumbai-based Biochem Pharmaceuticals for an undisclosed amount.
- Zydus plans to buy US drug cos for $60 mnZydus Cadila plans to acquire US-based generic pharma company. The Ahmedabad-based firm signed an asset purchase agreement with a US-based ...
- Zydus Cadila to market Maxisal in India, Nepal: US firmUS-based Amarillo Bio-sciences Inc (ABI) today said Indian pharmaceutical major Zydus Cadila will be marketing its dietary supplement Maxis...
- Cadila buys remaining 30 pc share in Zydua PharmaceuticalsDrug major, Cadila Healthcare Ltd today said it has purchased the remaining 30 per cent shares for an undisclosed amount in its US-based jo...
- Cadila to buy South African co Simayla PharmaceuticalsPharmaceutical firm Zydus Cadila on Monday said it will acquire 70% stake in South Africa-based generic firm Simayla Pharmaceuticals for an...
Load More
